Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.
Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.
Investigated for use/treatment in bacterial infection and rosacea.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.